The United States has approached Ghana to reopen discussions on a proposed US$109 million health compact that the Ghanaian government previously rejected over concerns about data protection, financial obligations and the country’s regulatory authority.
President John Dramani Mahama disclosed that the US had expressed interest in engaging Ghana again to address the issues that led to the rejection of the proposed agreement.
The five-year health compact was intended to support cooperation between the two countries in the health sector. However, the Ghanaian government raised concerns about some of the conditions attached to the arrangement, prompting it to decline the proposed deal.
One of the major issues involved provisions relating to the sharing of sensitive health information. Ghana expressed reservations about requirements concerning national pathogen profiles and citizens’ medical records, stressing the importance of protecting confidential health data.
The government’s position reflects concerns about how sensitive information could be accessed, managed and used under the proposed framework. Health data can contain information that is important to public health planning, disease surveillance and emergency responses, making its protection a key consideration in international health partnerships.
Ghana also raised questions about the financial commitments it would be expected to undertake under the agreement. Although the compact involved US$109 million, the government wanted clarity on the responsibilities and obligations that would fall on Ghana during the five-year period.
Another area of concern involved the authority of Ghana’s Food and Drugs Authority (FDA). The government reportedly questioned provisions that could affect the regulator’s ability to inspect medicines and other medical products entering the country.
The FDA plays a central role in protecting public health by regulating medicines, medical devices, food products and other regulated items. Its inspection and oversight powers are intended to help ensure that products available to the public meet applicable safety and quality standards.
The proposed compact therefore raised questions about how international health cooperation could be structured without undermining Ghana’s regulatory responsibilities or compromising the protection of citizens’ information.
Mahama indicated that the renewed engagement could provide an opportunity for both countries to revisit the disputed provisions. The discussions could focus on changing or removing clauses that Ghana considers unacceptable while identifying areas where cooperation remains possible.
The development suggests that the rejection of the original proposal has not necessarily ended the prospect of a health partnership between the two countries. Instead, further discussions could help establish whether an agreement can be reached on terms acceptable to both sides.
Ghana and the United States have a history of cooperation in health-related programmes, including efforts involving disease prevention, public health systems and medical services. Any revised agreement would need to address the concerns raised by the Ghanaian government while setting out clearly the responsibilities of both countries.
The renewed talks will be important in determining whether the proposed US$109 million compact can be restructured. Until the details of any revised agreement are made public, the final terms and the outcome of the discussions remain uncertain.
Source: Thepressradio.com
